V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 190010348 | 190005119 | 1.71 | 70.25 | Curative (C) | 2019-05-16 | 2019-05-16 | METHOTREXATE | 02 | N | METHOTREXATE | 100421315 |
| 190010350 | 190005120 | 1.93 | 47.4 | null | 2016-12-30 | 2017-01-02 | DOXORUBICIN | 02 | N | DOXORUBICIN | 100102702 |
| 190010353 | 190005121 | 1.95 | 56.4 | Palliative (P) | null | 2019-02-13 | EW Rel Irinotecan & Temozolomide | null | null | NOT MATCHED | 100566701 |
| 190010357 | 190005122 | 1.79 | 70 | null | 2017-04-18 | 2017-04-27 | EW EuroEwing 2012 Arm B IE | 02 | N | EW EUROEWING 2012 ARM B IE | 101238553 |
| 190010358 | 190005123 | 0 | 51.6 | null | null | 2020-05-02 | MAP | null | null | CISPLATIN + DOXORUBICIN + METHOTREXATE | 100958431 |
| 190010360 | 190005124 | 1.86 | 43 | null | 2019-06-12 | 2019-06-16 | Everolimus 10mg | Y | N | OST REL IFOSFAMIDE ETOPOSIDE | 100086863 |
| 190010363 | 190005125 | 1.66 | 77.9 | Palliative (P) | 2018-06-09 | 2018-06-10 | OST Euramos 1 Closed Trial - M | 02 | null | OST M | 101818627 |
| 190010364 | 190005126 | null | 57.4 | null | 2021-01-25 | 2021-01-27 | Irinotecan + Temozolomide | 02 | N | CYCLOPHOSPHAMIDE + VINCRISTINE | 100647797 |
| 190010371 | 190005127 | 0 | 23.8 | Neo-adjuvant (N) | 2019-06-29 | 2019-11-25 | OST Euramos 1 Closed Trial - A | 02 | N | DOXORUBICIN | 101082888 |
| 190010375 | 190005128 | 1.4 | 70.5 | null | 2021-04-27 | 2021-04-27 | Docetaxel+Gemcitabine (no prior RT) | 02 | N | DOCETAXEL + GEMCITABINE | 100484423 |
| 190010378 | 190005129 | 1.58 | null | null | 2019-01-02 | 2019-01-20 | METHOTREXATE | 02 | null | METHOTREXATE | 101604181 |
| 190010381 | 190005130 | 0 | 27.2 | Curative (C) | 2020-02-22 | 2020-02-22 | CYCLOPHOSPHAMIDE + DOXORUBICIN + VINCRISTINE | 02 | N | IFOSFAMIDE | 101291508 |
| 190010382 | 190005131 | 1.69 | 53.5 | Neo-adjuvant (N) | 2020-10-01 | 2020-10-09 | ETOPOSIDE + IFOSFAMIDE | 02 | N | ETOPOSIDE + IFOSFAMIDE | 100271314 |
| 190010386 | 190005133 | 1.14 | 42.8 | Palliative (P) | 2019-07-13 | 2019-12-30 | null | 02 | N | TRABECTEDIN | 100336689 |
| 190010390 | 190005134 | 1.88 | 66.7 | Curative (C) | 2021-03-08 | 2021-04-12 | EW EuroEwing 2012 Arm B VC | N | Y | EW EUROEWING 2012 ARM B VC | 101498304 |
| 190010411 | 190005135 | 1.68 | 57 | Curative (C) | 2019-11-27 | 2020-03-13 | ETOPOSIDE + IFOSFAMIDE + MESNA | 02 | N | ETOPOSIDE + IFOSFAMIDE | 100962338 |
| 190010413 | 190005136 | 1.83 | 64.65 | Palliative (P) | 2017-11-01 | 2018-04-30 | PAM x 2 pre-surgery (cycles 1&2) | 02 | N | CISPLATIN + DOXORUBICIN + METHOTREXATE | 101790227 |
| 190010414 | 190005137 | 1.81 | 16.8 | Curative (C) | 2017-03-08 | 2017-03-13 | Trial Unspecified | 02 | N | TRIAL UNSPECIFIED | 100303566 |
| 190010417 | 190005138 | 0 | 64.9 | Palliative (P) | null | 2018-11-28 | CYCLOPHOSPHAMIDE | null | null | STS NON-RHABDO EPSSG 2005 IVA | 100684600 |
| 190010421 | 190005139 | 1.81 | 54 | Curative (C) | 2019-08-21 | 2019-09-10 | DOXORUBICIN | N | N | DOXORUBICIN | 101655100 |
| 190010425 | 190005140 | 0 | 25.4 | Neo-adjuvant (N) | 2017-06-02 | 2017-06-07 | Cyclophosphamide + Topotecan | N | N | NB BEACON TEMOZOLOMIDE AND TOPOTECAN | 100927778 |
| 190010426 | 190005141 | 1.5 | 55.5 | Curative (C) | 2018-04-26 | 2018-11-11 | DOCETAXEL + GEMCITABINE | 02 | N | DOCETAXEL + GEMCITABINE | 100028690 |
| 190010429 | 190005142 | null | 82.7 | null | 2019-01-31 | 2019-02-09 | Doxorubicin 75mg/m2 | N | N | DOXORUBICIN | 101508866 |
| 190010450 | 190005143 | 1.75 | 59 | Palliative (P) | 2019-03-01 | 2019-03-01 | Cisplatin 100 + RT(H&N) 1 day | 02 | N | EW REL REECUR TOPOTECAN/CYCLOPHOSPHAMIDE | 101280855 |
| 190010453 | 190005144 | 1.73 | 56.5 | null | 2019-05-24 | 2019-06-28 | EW EuroEwing 2012 Arm B IE | null | null | DACTINOMYCIN + IFOSFAMIDE + VINCRISTINE | 100633818 |
| 190010454 | 190005145 | 1.72 | 49.95 | Curative (C) | 2018-11-17 | 2018-11-22 | METHOTREXATE | null | null | METHOTREXATE | 101277987 |
| 190010455 | 190005146 | 1.73 | 100 | Curative (C) | 2017-06-12 | 2017-11-13 | Methotrexate High Dose (3g/m2) | 02 | N | METHOTREXATE | 100331847 |
| 190010459 | 190005147 | 1.69 | 54.2 | Palliative (P) | 2014-11-14 | 2017-02-01 | EW EuroEwing 2012 Arm B VDC | 02 | null | DOXORUBICIN + METHOTREXATE | 101317669 |
| 190010462 | 190005148 | 1.69 | 72.1 | null | 2016-11-29 | 2016-11-29 | Ifosfamide | 01 | N | EW EUROEWING 2012 ARM A VAI | 101564620 |
| 190010465 | 190005149 | 1.62 | null | Palliative (P) | 2018-10-28 | 2018-12-04 | MAP | 02 | N | CISPLATIN + DOXORUBICIN + METHOTREXATE | 100989131 |
| 190010472 | 190005150 | 1.78 | 71.1 | Curative (C) | null | 2018-08-14 | CARBOPLATIN + ETOPOSIDE | null | null | EURAMOS TRIAL | 101104561 |
| 190010473 | 190005151 | 1.72 | 67.1 | Palliative (P) | 2020-05-14 | 2020-05-21 | STS Rhabdomyosarcoma RMS 2005 IVAVV | 02 | N | NOT MATCHED | 100010762 |
| 190010478 | 190005152 | 1.71 | 77.25 | null | 2019-07-28 | 2020-01-26 | Cyclophosphamide + Vincristine | 02 | null | CISPLATIN + DOXORUBICIN + METHOTREXATE + MIFAMURTIDE | 100185268 |
| 190010480 | 190005153 | 0 | 75.8 | Palliative (P) | 2017-08-10 | 2017-08-11 | Etoposide + Ifosfamide (5 days) | 02 | null | ETOPOSIDE + IFOSFAMIDE | 101828403 |
| 190010486 | 190005154 | 1.69 | 107.1 | null | 2018-11-23 | 2018-11-29 | OST Euramos 1 Closed Trial - A | 02 | null | OST A | 100312996 |
| 190010492 | 190005155 | 1.81 | 70.1 | null | 2013-10-15 | 2013-10-17 | OST Euramos 1 Closed Trial - A | null | null | OST A | 100561917 |
| 190010494 | 190005156 | 1.51 | 58 | Palliative (P) | 2020-01-13 | 2020-01-27 | DOCETAXEL + GEMCITABINE | 02 | N | DOCETAXEL + GEMCITABINE | 100165736 |
| 190010500 | 190005157 | 1.39 | 21 | Palliative (P) | 2018-08-06 | 2018-08-27 | MAP | 02 | null | CISPLATIN + DOXORUBICIN + METHOTREXATE | 101662835 |
| 190010509 | 190005158 | 1.9 | 76.9 | Curative (C) | 2017-11-30 | 2017-12-20 | DHAP | null | null | LIPOSOMAL DOXORUBICIN | 100277654 |
| 190010510 | 190005159 | 1.57 | 63.5 | Adjuvant (A) | 2017-02-23 | 2017-12-24 | EW EuroEwing 2012 Arm B VC | null | null | EW EUROEWING 2012 ARM B VC | 101045967 |
| 190010520 | 190005160 | 1.77 | 89 | Curative (C) | 2019-06-15 | 2019-06-15 | EW EuroEwing 2012 Arm B VC | 02 | N | EW EUROEWING 2012 ARM B VC | 101789681 |
| 190010523 | 190005161 | 1.41 | 95.1 | Adjuvant (A) | 2016-07-20 | 2016-08-08 | Cisplatin + Radiotherapy | N | null | EW REL REECUR IRINOTECAN/TEMOZOLOMIDE | 100632183 |
| 190010527 | 190005162 | 1.55 | 84 | Adjuvant (A) | 2018-07-06 | 2018-11-06 | OST Euramos 1 Closed Trial - A | 02 | N | DOXORUBICIN | 100768930 |
| 190010533 | 190005163 | 1.72 | 102 | 03 | 2019-12-29 | 2020-01-05 | OST Euramos 1 Closed Trial - M | 02 | null | MAP | 100312982 |
| 190010535 | 190005164 | 1.52 | 106.8 | Curative (C) | 2017-12-02 | 2017-12-23 | EW EuroEwing 2012 Arm B IE | N | N | EW EUROEWING 2012 ARM B IE | 101646211 |
| 190010537 | 190005165 | 0 | 10.8 | Adjuvant (A) | 2017-12-04 | 2017-12-04 | PACLITAXEL | 02 | null | STS NON-RHABDO EPSSG 2005 VDCY | 101289076 |
| 190010540 | 190005166 | 1.76 | 90.8 | null | 2018-12-26 | 2019-01-01 | PEMBROLIZUMAB | 01 | N | METHOTREXATE HIGH DOSE | 101310410 |
| 190010544 | 190005167 | 1.83 | 44.9 | 03 | null | 2019-09-16 | Ifosfamide 3g/m2 5 day | null | null | OST IE | 100047691 |
| 190010548 | 190005168 | 1.7 | 59.3 | null | 2017-03-29 | 2017-06-12 | Carboplatin + Etoposide iv&po | 02 | null | EW REL REECUR TOPOTECAN/CYCLOPHOSPHAMIDE | 100123357 |
| 190010549 | 190005169 | 1.79 | 49.7 | Adjuvant (A) | 2019-01-15 | 2019-02-05 | Trial Unspecified | 02 | null | ETOPOSIDE | 101624986 |